AIPLA Names HP&M Attorney to Chair Hatch-Waxman Group

The American Intellectual Property Law Association (“AIPLA”) has appointed Hyman, Phelps & McNamara, P.C. attorney Kurt R. Karst as Chair of the organization’s Hatch-Waxman Subcommittee of the Special Committee on the FDA.  “I am honored to have been nominated for this position, and look forward to raising AIPLA’s voice on myriad Hatch-Waxman issues” said Karst.  AIPLA’s Special Committee on the FDA is currently monitoring several issues, including Paragraph IV litigation and follow-on biologics.  Earlier this year, AIPLA sent a letter to FDA raising intellectual property issues about implementation of § 4 of the QI Program Supplemental Funding Act of 2008, which concerns old antibiotics.  Please contact Special Committee on the FDA Chair Myra H. McCormack (mmccorm1@corus.jnj.com), Vice-Chair Freddie K. Park (freddiep99@yahoo.com), or Kurt R. Karst (kkarst@hpm.com) if you are interested in becoming a member of the Special Committee on the FDA and the Hatch-Waxman Subcommittee.